CS logo
small CS logo
Saiseikai Kumamoto Hospital

Kumamoto, Japan
General hospital in Kumamoto
5 Chome-3番1号 Chikami, Minami Ward, Kumamoto, 861-4193

About Saiseikai Kumamoto Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Abbott Medical Devices
5
Boehringer Ingelheim
4
Pfizer
4
Associations for Establishment of Evidence in Interventions
2
Bayer
2
Daiichi Sankyo, Inc.
2
Galapagos NV
2
Hoffmann-La Roche
2
Medtronic Cardiac Rhythm and Heart Failure
2
Amgen
1
Boston Scientific Corporation
1
Total Rows: 21

Clinical Trials at Saiseikai Kumamoto Hospital


During the past decade, Saiseikai Kumamoto Hospital conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 16 clinical trials were completed, i.e. on average, 64% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 9 clinical trials were completed. i.e. 69.2% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11332244226622550022110044222233Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Japan-Drug Eluting Stents Evaluation; a Randomized Trial
2008-03-01
Completed
3,500
Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure
2010-07-01
2015-09-01
Completed
221
A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese Population
2010-04-01
2013-12-01
Completed
65
Japanese Assessment of Indication Based Programming
2010-08-01
2012-09-01
Completed
235
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
2011-05-15
2016-03-08
Terminated
1,000
The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)
2010-10-01
2011-04-01
Completed
47
Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients
2011-04-01
2013-12-01
Completed
1,187
Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets
2012-08-01
2015-12-01
Unknown status
800

Rows per page:

1–37 of 37

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Saiseikai Kumamoto Hospital" #1 sponsor was "Abbott Medical Devices" with 5 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Associations for Establishment of Evidence in Interventions" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 21 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saiseikai Kumamoto Hospital" #1 collaborator was "Abbott" with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Beijing Tiantan Hospital" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAbbott Medical Devices: 5Abbott Medical Devices: 5Boehringer Ingelheim: 4Boehringer Ingelheim: 4Pfizer: 4Pfizer: 4Associations forEstablishment ofEvidence inInterventions: 2Associations forEstablishment ofEvidence inInterventions: 2Bayer: 2Bayer: 2Daiichi Sankyo, Inc.: 2Daiichi Sankyo, Inc.: 2Galapagos NV: 2Galapagos NV: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2Medtronic CardiacRhythm and HeartFailure: 2Medtronic CardiacRhythm and HeartFailure: 2Amgen: 1Amgen: 1

Created with Highcharts 11.1.0Top CollaboratorsAbbott: 2Abbott: 2Medtronic: 2Medtronic: 2AstraZeneca: 1AstraZeneca: 1Beijing Tiantan Hospital: 1Beijing Tiantan Hospital: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1China MedicalUniversity Hospital: 1China MedicalUniversity Hospital: 1Daiichi Sankyo Co., Ltd.: 1Daiichi Sankyo Co., Ltd.: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Guidant Corporation: 1Guidant Corporation: 1

Clinical Trials Conditions at Saiseikai Kumamoto Hospital


According to Clinical.Site data, the most researched conditions in "Saiseikai Kumamoto Hospital" are "Coronary Artery Disease" (6 trials), "Idiopathic Pulmonary Fibrosis" (4 trials), "Heart Failure" (3 trials), "Myocardial Ischemia" (3 trials) and "Arrhythmias, Cardiac" (2 trials). Many other conditions were trialed in "Saiseikai Kumamoto Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Saiseikai Kumamoto Hospital


Most popular intervention types in "Saiseikai Kumamoto Hospital" are "Drug" (22 trials), "Device" (10 trials), "Other" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "BAY2433334" (2 trials), "BAY2433334 matching placebo" (2 trials), "GLPG1690" (2 trials) and "Nintedanib" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Saiseikai Kumamoto Hospital


The vast majority of trials in "Saiseikai Kumamoto Hospital" are 37 trials for "All" genders.

Clinical Trials Status at Saiseikai Kumamoto Hospital


Currently, there are NaN active trials in "Saiseikai Kumamoto Hospital". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Saiseikai Kumamoto Hospital, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Saiseikai Kumamoto Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 20Phase 3: 20Not Applicable: 8Not Applicable: 8Phase 2: 2Phase 2: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 19Completed: 19Active, not recruiting: 6Active, not recruiting: 6Recruiting: 6Recruiting: 6Terminated: 4Terminated: 4Unknown status: 2Unknown status: 2